Neervannan Seshadri
Tarsus Pharmaceuticals, Inc. · Chief Operating Officer
Neervannan Seshadri is listed in filings as Chief Operating Officer at Tarsus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 24, 2026, including sale activity. Recent filings connect the profile to Tarsus Pharmaceuticals, Inc. (TARS). The current snapshot covers public activity from Mar 7, 2025 to Mar 24, 2026. Reported amounts are shown as $199.5K to $248.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $307k4.6k shares | SellMar 19, 2026 | $67.00 | $60.06 | |
| $248k3.6k shares | SellMar 18, 2026 | $68.71 | $60.06 | |
| $217k3.1k shares | SellMar 17, 2026 | $69.42 | $60.06 | |
| $641k8.4k shares | SellMar 4, 2026 | $76.67 | $60.06 | |
| $122k2.4k shares | SellMar 20, 2025 | $50.11 | $60.06 | |
| $121k2.5k shares | SellMar 19, 2025 | $47.40 | $60.06 | |
| $121k2.6k shares | SellMar 18, 2025 | $46.29 | $60.06 |